Biodexa Pharmaceuticals Plc
BDRXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for BDRX. That does not mean none is planned.
Get an email about BDRX's next catalysts
Track Biodexa Pharmaceuticals (BDRX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
eRapa (encapsulated rapamycin)
Familial Adenomatous Polyposis (FAP)
Encapsulated Rapamycin (eRapa)
Familial Adenomatous Polyposis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
eRapa (encapsulated rapamycin) | Phase 3 | Familial Adenomatous Polyposis (FAP) | - | - |
Encapsulated Rapamycin (eRapa) | Phase 2 | Familial Adenomatous Polyposis | - | - |
Frequently asked questions
What is in Biodexa Pharmaceuticals Plc's drug pipeline?→
CatalystAlert tracks 2 drug candidates in Biodexa Pharmaceuticals Plc's (BDRX) pipeline across Phase 3, Phase 2. Its lead program is eRapa (encapsulated rapamycin) (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Biodexa Pharmaceuticals Plc's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Biodexa Pharmaceuticals Plc (BDRX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track BDRX biotech catalysts?→
Add BDRX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Biodexa Pharmaceuticals Plc's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.